Supplemental material
Journal of Medical Economics
Volume 22, 2019 - Issue 12
Open access
2,964
Views
6
CrossRef citations to date
0
Altmetric
Nephrology
Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker
Mauricio A. BerdugoMedical Affairs, bioMérieux Inc, Durham, NC, USA;
, Noam Y. KirsonAnalysis Group, Inc, Boston, MA, USA; Correspondence[email protected]
, Louise ZimmerMedical Affairs, bioMérieux Inc, Durham, NC, USA;
, Hadi BeyhaghiMedical Affairs, bioMérieux Inc, Durham, NC, USA;
, Seth TobackMedical Affairs, bioMérieux Inc, Durham, NC, USA;
, Lauren M. ScarpatiAnalysis Group, Inc, Boston, MA, USA;
, Michael N. StoneAnalysis Group, Inc, Boston, MA, USA;
, Ross DemberAnalysis Group, Inc, Boston, MA, USA;
, Joshua Tseng-ThamAnalysis Group, Inc, Boston, MA, USA;
, Jody WenAnalysis Group, Inc, Boston, MA, USA;
& Mark MillerMedical Office, bioMérieux SA, Marcy l’Etoile, France
show all
Pages 1281-1289
|
Received 09 May 2019, Accepted 21 Jun 2019, Published online: 15 Jul 2019
Related Research Data
Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker
Source:
Taylor & Francis
Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker
Source:
Taylor & Francis
Economic and clinical benefits of early identification of acute kidney injury using a urinary biomarker
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.